The optimization of iloprost inhalation under moderate flow of oxygen therapy in severe pulmonary arterial hypertension-Reference-Cited by-同舟云学术

The optimization of iloprost inhalation under moderate flow of oxygen therapy in severe pulmonary arterial hypertension

Published:2018-06 Issue:4 Volume:8 Page:1-8
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Nakayama Kazuhiko¹,Emoto Noriaki¹²,Tamada Naoki¹,Okano Mitsumasa¹,Shinkura Yuto¹,Yanaka Kenichi¹,Onishi Hiroyuki¹,Hiraishi Mana³,Yamada Shinichiro³,Tanaka Hidekazu¹,Shinke Toshiro¹,Hirata Ken‐ichi¹

Affiliation:

1. Division of Cardiovascular MedicineDepartment of Internal MedicineKobe University Graduate School of MedicineKobeJapan

2. Department of Clinical PharmacyKobe Pharmaceutical UniversityKobeJapan

3. Department of Cardiovascular MedicineKita Harima Medical CenterHyogoJapan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894018781537

Reference15 articles.

1. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis;Olschewski H;Am J Respir Crit Care Med,1999

2. Inhaled iloprost for severe pulmonary hypertension;Olschewski H;N Engl J Med,2002

3. Long‐term therapy with inhaled iloprost in patients with pulmonary hypertension;Olschewski H;Respir Med,2010

4. Efficacy and safety of inhaled iloprost in Japanese patients with pulmonary arterial hypertension ‐ Insights from the IBUKI and AIR Studies;Saji T;Circ J,2016

5. Bayer Pharma AG. Ventavis10 SmPC. Available at:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Product_Information/human/000474/WC500048691.pdf(accessed on 15 April 2018).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effects of Iloprost on Oxygenation During One-Lung Ventilation for Lung Surgery: A Randomized Controlled Trial;Journal of Clinical Medicine;2019-07-05

2. Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study;Pulmonary Circulation;2019-07